Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 liters of installed biologics drug substance manufacturing capacity, with scope for further expansion, and a high speed, commercial scale, fill-finish unit

webmaster Wednesday, July 05, 2023

their

Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.

webmaster Tuesday, December 17, 2024

your

Narotam Sekhsaria Scholarship Programme 2024

webmaster Wednesday, January 31, 2024

Technology

India’s Quantum leap with 85% of Industry leaders calling for major investments in Quantum Computing, reports Primus Partners

webmaster Monday, November 11, 2024

Profit

2600 Non Profit Jobs,

webmaster Thursday, May 17, 2018